These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15234390)

  • 1. [Neonatal anaemia secondary to rhesus incompatibility treated by recombinant erythropoietin].
    Kayemba-Kay's S; Christin P; Yahouanc-Lapalle H; Oriot D
    Arch Pediatr; 2004 Jul; 11(7):868-9. PubMed ID: 15234390
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of erythropoietin in a pregnant Jehovah's Witness with sickle-cell disease.
    Tan TL; Ahmad H; Jhavar R; Patel R; Harrison C; Oteng-Ntim E
    J Obstet Gynaecol; 2007 Jan; 27(1):82-3. PubMed ID: 17365469
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant human erythropoietin in a triplet pregnancy: a case report.
    Lialios G; Kallitsaris A; Bourantas KL; Messinis IE
    J Reprod Med; 2005 Nov; 50(11):863-6. PubMed ID: 16419637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization.
    Zuppa AA; Alighieri G; Calabrese V; Visintini F; Cota F; Carducci C; Antichi E; Noia GA; Fortunato G; Romagnoli C
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e95-101. PubMed ID: 20216236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses.
    Ball AM; Winstead PS
    Pharmacotherapy; 2008 Nov; 28(11):1383-90. PubMed ID: 18956998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of recombinant human erythropoietin (EPO-alfa) in a mother alloimmunized to the Js(b) antigen.
    Santolaya-Forgas J; Vengalil S; Duval J; Gottmann D; Meyer W; Gauthier D; DeChristopher PJ
    J Matern Fetal Med; 1999; 8(3):141-5. PubMed ID: 10338071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erythropoietin treatment for late anaemia after haemolytic disease of the newborn].
    Alvarez Domínguez E; Pérez Fernández JM; Figueras Aloy J; Carbonell Estrany X
    An Pediatr (Barc); 2010 Dec; 73(6):334-9. PubMed ID: 20970396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin.
    Wacker P; Ozsahin H; Stelling MJ; Humbert J
    Pediatr Hematol Oncol; 2001 Jun; 18(4):279-82. PubMed ID: 11400653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin use in a pregnant Jehovah's witness with anemia and beta-thalassemia: a case report.
    Bennett M; Macri CJ; Bathgate SL
    J Reprod Med; 2005 Feb; 50(2):135-7. PubMed ID: 15755051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodless treatment of infants with haemolytic disease.
    Lakatos L
    Arch Dis Child; 2004 Nov; 89(11):1076. PubMed ID: 15499070
    [No Abstract]   [Full Text] [Related]  

  • 11. The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level.
    Erduran E; Bahadir A
    Pediatr Hematol Oncol; 2011 Nov; 28(8):721-2. PubMed ID: 21875319
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of anaemia of nephrotic syndrome with recombinant human erythropoietin.
    Bayés B; Serra A; Juncà J; Lauzurica R
    Nephrol Dial Transplant; 1998 Jul; 13(7):1894-5. PubMed ID: 9681764
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe, life-threatening renal anemia treatment in patients who do not accept heterologous blood transfusion for religious reasons--case report].
    Jaroszyński AJ; Bober-Palak E; Jóźwiak L; Ksiazek A
    Przegl Lek; 2007; 64(7-8):528-30. PubMed ID: 18409359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for erythropoietin in neonatal medicine?
    Mainie P
    Early Hum Dev; 2008 Aug; 84(8):525-32. PubMed ID: 18653293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Response to recombinant human erythropoietin of anemia secondary to pressure ulcers in a patient with multiple sclerosis].
    Sánchez Marín B; Grasa JM; García Erce JA; Pérez Lungmus G
    Rev Neurol; 2001 Nov 16-30; 33(10):997-8. PubMed ID: 11785020
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anaemia, cardiac failure and erythropoietin].
    Cohen Solal A; Beauvais F
    Arch Mal Coeur Vaiss; 2005 Oct; 98(10):997-1001. PubMed ID: 16294546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fetomaternal incompatibility due to Rhesus erythrocyte antigens other than antigen D].
    Faille N; Kremp O; Risbourg B; Olewniczak G; Maingourd Y; Dieval J; Delobel J
    Ann Pediatr (Paris); 1984 Oct; 31(8):657-60. PubMed ID: 6437316
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant erythropoietin for treatment of anaemia in HIV-infected children.
    Caselli D; Maccabruni A; Zuccotti GV; Riva E; Fundaro C; Portelli V; Galli L; Zizzadoro P; Gabiano C; Forni GL
    AIDS; 1996 Jul; 10(8):929-31. PubMed ID: 8828757
    [No Abstract]   [Full Text] [Related]  

  • 19. [Human recombinant erythropoietin and anemia in premature infants of parents who are Jehovah's Witnesses].
    Velin P; Dupont D; Puig C; Golkar A
    Arch Fr Pediatr; 1993 Oct; 50(8):721-2. PubMed ID: 8002751
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question.
    Alaqeel AA
    Pan Afr Med J; 2019; 32():120. PubMed ID: 31223410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.